Navigation Links
New Colorectal Module From Simbionix Advances Laparoscopic Cancer Treatment
Date:11/26/2008

CLEVELAND, Ohio and LOD, Israel, November 26 /PRNewswire/ -- Simbionix USA Corp, an international company using leading edge simulation to advance clinical performance, announces the world-wide release of a breakthrough training simulation of the laparoscopic colorectal procedure.

Although minimally invasive surgical (MIS) techniques provide many advantages over traditional open surgery, surgeons have been slow to adopt laparoscopic colon resection, because it is a very challenging procedure to learn without potentially putting patients at risk. Colorectal resection is the most common treatment for colorectal cancer, which accounts for almost 10% of all cancer deaths in the US annually. The US National Institutes of Health (NIH) ranks colorectal cancer as the 4th most common type in the United States, with over 148,000 Americans diagnosed in 2008.

This new, virtual reality simulation, properly used, will significantly assist surgeons in mastering and perfecting their skills, in performing this critical cancer procedure, without posing a risk to patients during the learning process. The Laparoscopic Colorectal Procedure simulation joins the suite of training simulations available on Simbionix's critically acclaimed LAP Mentor(TM) which now offers training opportunities on seven different laparoscopic procedures and over 60 different patient scenarios.

"Our new laparoscopic colorectal module is definitely a revolution in the world of virtual reality medical simulation," explains Simbionix President, Ran Bronstein. "We've created a virtual 3D environment featuring the complex anatomical structures a surgeon would encounter in a real laparoscopic colorectal resection. Combined with the unique simulation capabilities that I believe only Simbionix can provide, the virtual module allows unlimited procedural interaction and is a definite leap forward in medical simulation."

The Simbionix Laparoscopic Colorectal Procedure simulation received international praise at the September 2008, 11th World Congress of Endoscopic Surgery and the Japanese Society of Endoscopic Surgery (JSES), and at the American College of Surgery (ACS) in San Francisco, CA in October. Professor Watanabe, head of the JSES, said: "It is very exciting to have a way of training how to perform and master this critical procedure. I am sure we will use it to train our surgeons."

Conor P. Delaney, Professor of Surgery, Chief, Division of Colorectal Surgery at Case Western Reserve University, is also excited about the new module. "The laparoscopic colorectal module will transform the way we teach laparoscopic colorectal surgery. I see this as an important part of training, where trainees learn the basic steps on a simple trainer, and then practice their first 20 cases on the Simbionix simulator. That way, by the time they need to perform in a clinical situation, they are already experienced with the procedure."

Simbionix is a global leader in medical simulation technology. Simbionix mission is to provide state of the art, computer-assisted metrics-based surgical simulation systems, and set the standard for minimally invasive surgical training and performance.

Simbionix products provide medical experts with hands-on training in a comprehensive array of MIS procedures, including; GI Endoscopy, Endourology, percutaneous access, advanced laparoscopic procedures and Endovascular procedures. http://www.simbionix.com

    Contact:

    Inbal Mazor
    VP Marketing
    Simbionix
    inbal@simbionix.com
    Tel: +1-216-229-2040


'/>"/>
SOURCE Simbionix Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. GeneNews appoints Canadian Colorectal Cancer Advisory Board
2. InNexus Biotechnology Announces New EGFR Antibody DXL1218 Targeting Colorectal Cancer and Announces $1.25 Million Private Placement
3. Poniard Announces Positive Incremental Efficacy and Safety Data from Phase 2 Picoplatin Trial in Patients With Metastatic Colorectal Cancer
4. NOTICE OF YM BIOSCIENCES CONFERENCE CALL TO DISCUSS PHASE II DATA FOR NIMOTUZUMAB IN METASTATIC COLORECTAL CANCER
5. GeneNews launches worlds first blood test for colorectal cancer screening
6. Genmab Initiates Zalutumumab Combination Study in Colorectal Cancer
7. Enterix Inc. Launches Its Point-of-Care Test for Colorectal Cancer Screening
8. GeneNews reports positive results from validation study of colorectal cancer biomarkers in late-breaking abstract at AACR
9. Quest Diagnostics Campaign Challenges Colorectal Cancer Screening Status Quo
10. Quest Diagnostics to Develop Blood Test to Aid in the Detection of Colorectal Cancer
11. Medicsight Welcomes U.S. Initiative to Reimburse CT Colonography for Early Detection of Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... ... 2017 , ... IsoPlexis Corporation (IsoPlexis), a venture capital-funded life ... through a single-cell precision engineering platform, today announced it has received an exclusive ... laboratory of Dr. James Heath at the California Institute of Technology, a pioneer ...
(Date:3/27/2017)... Yorba Linda, Ca (PRWEB) , ... March 27, ... ... and metastatic colorectal cancer (mCRC) generally produce small, heterogeneous samples with limited tumor ... progress, analytical challenges remain to be resolved, such as the need for reliable ...
(Date:3/27/2017)... 27, 2017  The global market for clinical ... to a new report from Kalorama Information.  In ... performed to evaluate disease progression, monitor drug treatment ... reasons.  The healthcare market research firm,s report, ... an overview of the medical laboratory industry and ...
(Date:3/27/2017)... , March 27, 2017 The ... to a comprehensive library of reports on Valero Energy ... transportation fuels and petrochemical industries. ...      (Logo: http://photos.prnewswire.com/prnh/20160330/349511LOGO) ... biofuel production to go green. Ethanol today, even though touted ...
Breaking Biology Technology:
(Date:3/6/2017)... SAN MATEO, Calif. , March 6, 2017 ... predictive marketing and sales technology, today announced Predictive ... (AI) solution for infusing actionable sales intelligence into ... customers to automatically enable their sales organizations with ... contextual messages that allow for intelligent engagement. Predictive ...
(Date:3/2/2017)... 2017 Summary This report provides ... KGaA and its partnering interests and activities since 2010. ... Description The Partnering Deals and Alliance since 2010 report ... one of the world,s leading life sciences companies. ... to ensure inclusion of the most up to date ...
(Date:3/2/2017)... Australia , March 2, 2017 Australian ... Ltd (ASX: CYP), has signed an agreement with ... from the Monash Biomedicine Discovery Institute and Department of ... to conduct a further preclinical study to support the ... treatment of asthma.  Asthma is a ...
Breaking Biology News(10 mins):